Učitavanje...
Dexmedetomidine for the management of awake fibreoptic intubation
BACKGROUND: Awake fibreoptic intubation (AFOI) frequently requires sedation, anxiolysis and relief of discomfort without impairing ventilation and depressing cardiovascular function. The goal is to allow the patient to be responsive and co‐operative. Medications such as fentanyl, remifentanil, midaz...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2014
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8095023/ https://ncbi.nlm.nih.gov/pubmed/24442817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009798.pub2 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|